Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...
Discover how to access company financial reports and SEC filings through investor relations sections and the EDGAR database for informed investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results